Skip to main content
Retour
PMCUF logo

Pro Medicus Limited

Qualité des données : 100%
PMCUF
OTC Healthcare Medical - Healthcare Information Services
84,50 €
▼ 0,95 € (-1,11%)
Cap. Boursière : 8,83B
Fourchette du Jour
82,00 € 85,45 €
Fourchette 52 Semaines
74,52 € 218,25 €
Volume
211
Moyenne 50J / 200J
105,68 € / 163,67 €
Clôture Précédente
85,45 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E 76,6 0,3
P/B 34,4 3,0
ROE % 51,8 3,7
Net Margin % 54,1 3,8
Rev Growth 5Y % 33,1 10,0
D/E 0,0 0,2

Objectif de Cours des Analystes

Hold
155,00 € +83.4%
P/E Prévisionnel
49,33
BPA Prévisionnel
1,73 €
Croissance BPA (est.)
+0,0%
CA Est.
294,49M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 0,00 €
0,00 € – 0,00 €
540,17M 0
FY2029 3,62 €
3,32 € – 3,90 €
595,95M 1
FY2028 2,49 €
2,28 € – 2,68 €
472,87M 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-11 0,66 € 1,09 € +65,7%
2025-08-12 0,38 € 0,40 € +3,7%
2025-02-13 0,30 € 0,31 € +0,7%
2024-08-14 0,28 € 0,30 € +7,5%
2024-02-15 0,25 € 0,24 € -4,7%
2023-06-30 0,20 € 0,21 € +3,9%
2022-12-31 0,17 € 0,18 € +5,0%
2022-06-30 0,16 € 0,16 € +0,9%

Dividend History

7 yr streak

Yield

0,00%

Payout Ratio

0,43%

Growth (3Y)

31,55%

Growth (5Y)

33,32%

Ex-Date Payment Date Amount Yield
Feb 27, 2026 Mar 20, 2026 0,23 € 0,53%
Sep 04, 2025 Sep 25, 2025 0,20 € 0,18%
Feb 28, 2025 Mar 21, 2025 0,16 € 0,19%
Sep 05, 2024 Sep 26, 2024 0,15 € 0,26%
Feb 29, 2024 Mar 22, 2024 0,12 € 0,34%
Sep 06, 2023 Sep 28, 2023 0,11 € 0,42%
Mar 02, 2023 Mar 24, 2023 0,09 € 0,41%
Sep 08, 2022 Sep 30, 2022 0,08 € 0,42%
Mar 03, 2022 Mar 25, 2022 0,07 € 0,39%
Sep 09, 2021 Oct 01, 2021 0,06 € 0,27%
Mar 04, 2021 Mar 19, 2021 0,05 € 0,29%
Sep 10, 2020 Oct 02, 2020 0,04 € 0,45%
Mar 05, 2020 Mar 20, 2020 0,04 € 0,55%
Sep 12, 2019 Oct 04, 2019 0,03 € 0,24%
Mar 12, 2019 May 17, 2019 0,02 € 0,37%
Mar 07, 2019 Mar 22, 2019 0,02 € 0,46%
Sep 06, 2018 Sep 27, 2018 0,03 € 0,58%
Mar 08, 2018 Mar 23, 2018 0,02 € 0,59%
Sep 07, 2017 Sep 28, 2017 0,02 € 0,78%
Mar 09, 2017 Mar 24, 2017 0,01 € 0,65%

Points Clés

Revenue grew 33,08% annually over 5 years — strong growth
Earnings grew 39,16% over the past year
ROE of 51,82% indicates high profitability
Net margin of 54,12% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 103,96M in free cash flow

Croissance

Revenue Growth (5Y)
33,08%
Revenue (1Y)31,83%
Earnings (1Y)39,16%
FCF Growth (3Y)33,50%

Qualité

Return on Equity
51,82%
ROIC45,60%
Net Margin54,12%
Op. Margin74,03%

Sécurité

Debt / Equity
0,01
Current Ratio6,49
Interest Coverage0,00

Valorisation

P/E Ratio
76,62
Forward P/E49,33
P/B Ratio34,35
EV/EBITDA54,92
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 31,83% Revenue Growth (3Y) 30,56%
Earnings Growth (1Y) 39,16% Earnings Growth (3Y) 37,83%
Revenue Growth (5Y) 33,08% Earnings Growth (5Y) 39,02%
Profitability
Revenue (TTM) 212,91M Net Income (TTM) 115,22M
ROE 51,82% ROA 34,02%
Gross Margin 99,85% Operating Margin 74,03%
Net Margin 54,12% Free Cash Flow (TTM) 103,96M
ROIC 45,60% FCF Growth (3Y) 33,50%
Safety
Debt / Equity 0,01 Current Ratio 6,49
Interest Coverage 0,00
Dividends
Dividend Yield 0,00% Payout Ratio 0,43%
Dividend Growth (3Y) 31,55% Dividend Growth (5Y) 33,32%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 76,62 Forward P/E 49,33
P/B Ratio 34,35 P/S Ratio 41,46
PEG Ratio 6,50 Forward PEG N/A
EV/EBITDA 54,92 Fwd EV/EBITDA 36,18
Forward P/S 29,98 Fwd Earnings Yield 2,03%
FCF Yield 1,18%
Market Cap 8,83B Enterprise Value 8,66B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 212,91M 161,50M 124,90M 93,46M 67,88M
Net Income 115,22M 82,79M 60,65M 44,44M 30,85M
EPS (Diluted) 1,10 0,79 0,58 0,43 0,30
Gross Profit 212,60M 161,20M 92,37M 92,94M 46,66M
Operating Income 157,61M 114,84M 86,20M 64,93M 44,42M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 338,70M 257,43M 202,14M 157,05M 125,57M
Total Liabilities 81,74M 69,70M 63,36M 55,32M 43,89M
Shareholders' Equity 256,96M 187,73M 138,78M 101,73M 81,68M
Total Debt 2,26M 2,07M 1,85M 2,28M 2,62M
Cash & Equivalents 174,54M 60,06M 91,25M 63,66M 42,04M
Current Assets 280,09M 206,56M 163,79M 119,82M 87,57M
Current Liabilities 43,14M 34,56M 30,85M 26,86M 17,62M

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#48 of 158
71

Activité Récente

Entré Growth Investing (Philip Fisher)
Mar 24, 2026